Stephan’s practice focuses on M&A transactions, carve-outs, joint ventures, buy and builds and reorganisations as well as general corporate law and corporate governance matters.
His clients include strategic and institutional investors (Corporates / Private Equity). With his extensive transactional experience of almost two decades he advises clients especially in the chemical, life sciences, healthcare, industrials, automotive, technology, financial services and retail sector.
Stephan is intimately familiar with the specifics of these industries, among other things due to his previous work as Group General Counsel of a global chemical and pharmaceutical group. Stephan is highly regarded by his clients thanks to his pragmatic advisory practice and his proactive entrepreneurial advisory approach with vision.
|Since 2019||Salary Partner, Taylor Wessing Germany|
|2014 – 2019||Group General Counsel, International Chemical Investors Group (ICIG), Frankfurt am Main|
|2011 – 2014||Senior Associate, Taylor Wessing, M&A, Private Equity, Venture Capital, Frankfurt am Main|
|2008 – 2011||Associate, Hogan Lovells, Private Equity, M&A|
|2008||Admitted as a lawyer, Frankfurt am Main|
|2008||Admitted as solicitor, England & Wales|
|2007||LL.M., International Commercial Law, University of Nottingham, England|
|2006||Second legal state exam, Bar Exam, Düsseldorf|
|2003||First legal state exam, Münster / Hamm|
|1998 – 2000||English legal studies, University of Münster|
Taylor Wessing advises Mercurius Health on the acquisition of MEDICLIN Robert Janker Klinik
Taylor Wessing advises International Chemical Investors Group on acquisition of Evonik's Lülsdorf chemical site
ICIG has been advised on the deal by a team led by M&A partners Stephan Doom and Michael Stein
Taylor Wessing advises International Chemical Investors Group on acquisition of inprotec AG
Taylor Wessing advises Azenta Life Sciences on the acquisition of the Barkey Group